Xu Rong, Wu Hao, Zhang Shiying, Zhou Heng, Liang Liang
Department of Medical Oncology, People's Hospital of Xinjiang Uygur, Urumqi, China.
Department of Pathology, Renmin Hospital of Wuhan University, Hubei Zhang Road (formerly Ziyang Road) Wuchang District No. 99 Jiefang Road 238, Wuhan, Hubei province, China.
Neurosci Lett. 2018 Sep 14;683:69-74. doi: 10.1016/j.neulet.2018.06.044. Epub 2018 Jun 25.
Many studies have reported that MTHFR C677T (rs 1801133) polymorphism is associated with the risk of alcohol dependence(AD). However, there are conflicting results regarding this relationship. In this article, we performed a meta-analysis of case-control studies to assess synthetically the influence of MTHFR C677T polymorphism on the risk of AD. All relevant studies were searched from Cochrane Library, EmBase, PubMed, and Web of science. 7 studies were included to evaluate the strength of associations between the MTHFR C677T polymorphism and AD by pooled odds ratios (ORs) and 95% confidence intervals (CIs). The present meta-analysis evaluated a total of 1066 AD patients and 1049 controls and showed that MTHFR C677T polymorphism was not significantly associated with AD susceptibility in all five genetic models (Allelic, T vs C: OR = 1.04,95% CI: 0.83-1.31, P = 0.73; Homozygous, TT vs CC: OR = 0.98,95% CI: 0.57-1.68, P = 0.94; Heterozygous, TT vs CT: OR = 0.87,95% CI: 0.64-1.19, P = 0.39; Dominant, TT + CT vs CC: OR = 1.12,95% CI: 0.92-1.35, P = 0.26; Recessive, TT vs CT + CC: OR = 0.93,95% CI: 0.58-1.47, P = 0.74). On subgroup analysis by ethnicity, there was still insignificant association was detected in the Caucasians and Asians under the five genetic models respectively. In conclusion, the present data revealed that MTHFR C677T polymorphism may not be associated with AD susceptibility. Further well designed studies in a larger population and biological functional analysis of MTHFR are needed to elucidate the role of MTHFR C677T Gene polymorphism in AD.
许多研究报告称,亚甲基四氢叶酸还原酶(MTHFR)C677T(rs1801133)基因多态性与酒精依赖(AD)风险相关。然而,关于这种关系的研究结果存在冲突。在本文中,我们进行了一项病例对照研究的荟萃分析,以综合评估MTHFR C677T基因多态性对AD风险的影响。从考克兰图书馆、EmBase、PubMed和科学网检索了所有相关研究。纳入7项研究,通过合并比值比(OR)和95%置信区间(CI)评估MTHFR C677T基因多态性与AD之间关联的强度。本荟萃分析共评估了1066例AD患者和1049例对照,结果显示,在所有五种遗传模型中,MTHFR C677T基因多态性与AD易感性均无显著关联(等位基因,T对C:OR = 1.04,95%CI:0.83 - 1.31,P = 0.73;纯合子,TT对CC:OR = 0.98,95%CI:0.57 - 1.68,P = 0.94;杂合子,TT对CT:OR = 0.87,95%CI:0.64 - 1.19,P = 0.39;显性,TT + CT对CC:OR = 1.12,95%CI:0.92 - 1.35,P = 0.26;隐性,TT对CT + CC:OR = 0.93,95%CI:0.58 - 1.47,P = 0.74)。按种族进行亚组分析时,在白种人和亚洲人的五种遗传模型中分别仍未检测到显著关联。总之,目前的数据表明,MTHFR C677T基因多态性可能与AD易感性无关。需要在更大规模人群中进行进一步精心设计的研究以及对MTHFR进行生物学功能分析,以阐明MTHFR C677T基因多态性在AD中的作用。